CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED...

Neuro-Oncology 2019 / 11 Vol. 21; Iss. Supplement

CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY

Heist, Rebecca S, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J M, Tan, Daniel S W, Hida, Toyoaki, de Jonge, Maja, V Orlov, Sergey, Smit, Egbert F, Souquet, Pierre-Jean,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz175.223
Date:
November, 2019
File:
PDF, 96 KB
english, 2019
Conversion to is in progress
Conversion to is failed